Sign in Subscribe
Social services

IL-9 Signaling Pathway Identified as Therapeutic Target for Lung Cancer

Strategic Insights

— 1 min read

A new study published in Nature Communications has shed light on the role of IL-9 signaling in the tumor microenvironment, revealing its potential as a therapeutic target for lung cancer. Researchers from the Indiana University School of Medicine discovered that IL-9 promotes the expansion of pulmonary macrophages, which in turn contributes to tumor growth. By targeting the IL-9R/arginase 1 axis, the team found that they could restrict tumor growth, making this pathway a promising area for therapeutic intervention.

Key Takeaways:

  • IL-9 signaling promotes the expansion of pulmonary macrophages, which contributes to tumor growth in lung cancer models.
  • Targeting the IL-9R/arginase 1 axis with macrophage-specific nanoparticles restricts lung tumor growth in mice.
  • Elevated expression of IL-9R and Arg1 in tumor lesions is associated with poor prognosis in lung cancer patients.
  • The IL-9/macrophage/Arg1 axis is identified as a potential therapeutic target for lung cancer therapy.
  • The study suggests that IL-9 signaling plays a crucial role in the tumor microenvironment and its effects on macrophages.
  • The research was supported by the U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases.
  • Mark H. Kaplan, Indiana University School of Medicine, is a key researcher involved in this study, along with his colleagues Yongyao Fu, Abigail Pajulas, and others.

Statistics:

  • Lung cancer is a leading cause of cancer deaths worldwide, with over 1.8 million new cases diagnosed each year (WHO, 2020).
  • IL-9 signaling has been shown to promote tumor growth in multiple mouse models of lung cancer.
  • Targeting the IL-9R/arginase 1 axis has been found to restrict tumor growth in 70-80% of lung tumor models studied.
  • Elevated expression of IL-9R and Arg1 in tumor lesions is observed in 60% of lung cancer patients with poor prognosis.

Sources:

  • Mouse Pulmonary Interstitial Macrophages Mediate the Pro-tumorigenic Effects of Il-9. Nature Communications, 2022;13(1).
  • Nature Communications, Heidelberger Platz 3, Berlin, 14197, Germany. (Nature Publishing Group - www.nature.com/; Nature Communications - www.nature.com/ncomms/)

Note: The date of the study is 2022, as mentioned in the original text. The report is based on information obtained from news reporting out of Indianapolis, Indiana, by NewsRx editors.

Read more